SEQUENCING OF 120 MRNA SAMPLES USING ILLUMINA NEXT GENERATION SEQUENCING (NGS) Solicitation ID/Procurement Identifier: 75F40120P00352 Ultimate Completion Date: Thu Jul 08 17:00:00 GMT 2021
) generating up to 15Gb of high quality data, capable of 22-25 million reads per run and capable of conducting small genome de novo sequencing, small RNA sequencing and 16S metagenomics.
Reaching both these goals rely heavily on high-throughput sequencing of amplicon libraries, which is best conducted on Illumina MiSeq Next Generation Sequencing platform.Period of Performance: Base Year plus one (1) Option Year.A determination by the Government not to compete this requirement based on responses to this notice is within the discretion of the Government.
The Centers for Disease Control and Prevention (CDC) located in 1600 Clifton Road NE, Atlanta Georgia, intends to award a sole source, Firm Fixed Price contract for Next Generation Sequencing Miseq Illumina System to BIOMEDIC SCIENCE MATERIAL JOINT STOCK COMPANY, 3rd Floor, T2 Times Tower, 35 Le Van Luong, Nhan, Ha Noi, Vietnam, to assist the Ministry of Health with the establishment of a National Public Health Reference Laboratory network.
The Centers for Disease Control and Prevention intends to award a sole source firm-fixed-price purchase order under FAR Part 13.5 procedures to Illumina Inc. to estabhish a laboratory maintenance agreement for on-site preventative and remedial maintenance of Illumina MiSeq, MiSeqDX and NextSeq 550 next-generation sequencing systems and components attached to these instruments, as well as any Illumina equipment that may be replaced/exchanged and added
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Illumina, Inc., San Diego, CA, for their MiSeq Reagent Kit for ongoing laboratory use with the Illumina Next-Generation Sequencing Platform, only available through the company.
This is a combined synopsis/solicitation for commercial items, prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice, and shall be processed in accordance with FAR Part 13.5 – Simplified Procedures for Certain Commercial Items. This announcement constitutes the only solicitation; quotations are being requested and a separate, written solicitation will not be issued. This solicitation, 75N91022Q00075, is issued as a request for quotation (RFQ) and includes all applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2022-04 (01/30/2022), simplified acquisition procedures for commercial items.Please see the attached RFQ for additional informatio...
